【结 构 式】 |
【分子编号】40748 【品名】 【CA登记号】 |
【 分 子 式 】C22H26N2O6S3 【 分 子 量 】510.65632 【元素组成】C 51.75% H 5.13% N 5.49% O 18.8% S 18.84% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(I)Rearrangement of leinamycin (I) to thioester (III) was achieved by treatment with 4-chloromethyl-5-methyl-2-oxo-1,3-dioxolene (II) in the presence of KI and K2CO3. The required tetrahydropyranyl ether was then obtained by condensation of (III) with dihydropyran (IV) employing camphorsulfonic acid as the catalyst.
【1】 Kanda, Y.; Kono, M.; Kakita, S.; Takahashi, Y.; Yoshida, M.; Saitoh, Y.; Okabe, M.; Ashizawa, T.; Synthesis and antitumor activity of novel thioester derivatives of leinamycin. J Med Chem 1999, 42, 8, 1330. |
【2】 Kanda, Y.; Saitoh, Y.; Saito, H.; Ashizawa, T.; Sugiyama, K.; Gomi, K.; Kakita, S.; Takahashi, Y.; Murakata, C. (Kyowa Hakko Kogyo Co., Ltd.); DC107 derivs.. EP 0786462; US 5733924; WO 9700260 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 40748 | C22H26N2O6S3 | 详情 | 详情 | ||
(II) | 16911 | 4-(chloromethyl)-5-methyl-1,3-dioxol-2-one | C5H5ClO3 | 详情 | 详情 | |
(III) | 40749 | (2R,12R,17R)-12-hydroxy-17-((1R)-1-hydroxy-1-methyl-2-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]sulfanyl]-2-oxoethyl)-2,14-dimethyl-11,19-dioxo-4-thia-20-thionia-1,21-diazatricyclo[15.2.1.1(3,6)]henicosa-3(21),5,7,9,13-pentaen-20-olate | C27H30N2O9S3 | 详情 | 详情 | |
(IV) | 13684 | 3,4-Dihydro-2H-pyran;2,3-Dihydro-4H-pyran; 5,6-Dihydro-4H-pyran;Dihydropyran | 110-87-2 | C5H8O | 详情 | 详情 |
Extended Information